Fierce Pharma: As U.S. calls for stateside manufacturing, antibiotic maker Paratek gambles on 'onshoring' effort
Paratek Pharmaceuticals, maker of antibiotic Nuzyra, is kick-starting a three-year plan to build a government-funded, second supply chain in the U.S. in an effort to flesh out the nation's strategic supply of pandemic response drugs.
No comments:
Post a Comment